Friday 17 September
Homologous Recombination Deficiency: BRCA and Beyond
Friday, 08:45 - 09:50
View the satellite invitation
The Role of Biomarkers in Patient Management in Immuno-Oncology
Friday, 10:30 - 11:30
View the satellite invitation
Evolving Treatment Landscape in HNSCC
Friday, 18:45 - 20:15
View the satellite invitation
Saturday 18 September
Advances in Antibody Drug Conjugates in Solid Tumors: Current Treatments and Emerging Therapies
Saturday, 18:45 - 20:15
View the satellite invitation
Sunday 19 September
Biomarkers for Cancer Immunotherapy: The Importance of dMMR/MSI-H for Predicting Response in Solid Tumors
Sunday, 18:45 - 20:15
Tuesday 21 September
Leveraging Antibody-Drug Conjugates in Cancer Care: Evolving Approaches to Bridge Clinical Gaps in Breast, GI, and Lung Tumors
Tuesday, 10:30 - 12:00
View the satellite invitation
Extend the Continuum of Care and Improve Patient Outcomes in mGC and mCRC
Tuesday, 17:35 - 19:05
View the satellite invitation
Immuno-Oncology for GI Cancers: A Clinical Lens on Current Data
Tuesday, 17:35 - 19:05
View the satellite invitation
Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.
View the complete ESMO Congress 2021 Industry Sponsored Satellite Symposia Programme